Vnitr Lek 2010, 56(2):162-164

Jubileum Ing. Kataríny Derzsiovej

M. Mydlík*, V. Spustová

Received: January 4, 2010; Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mydlík M, Spustová V. Jubileum Ing. Kataríny Derzsiovej. Vnitr Lek. 2010;56(2):162-164.
Download citation

References

  1. Berčík J, Čakrt M, Derzsiová K. Použitie uhlíkových indikačných elektród pri neutralizačných potenciometrických titráciách (II). Grafitová elektróda v prostredí metyletylketónu. Chem Zvesti 1968; 22: 761-767.
  2. Derzsiová K, Mydlík M. Úloha laboratória v nefrologickej diagnostike z pohľadu praktického lekára. Lab Diagnostika 2008; 17: 26-31.
  3. Mydlík M, Derzsiová K, Cesnak D et al. Selektivita glomerulárnej proteinúrie pri renálnej insuficiencii. Čas Lék Čes 1977; 116: 694-697.
  4. Mydlík M, Derzsiová K, Žemberová E. Influence of water and sodium diuresis and furosemide on urinary excretion of vitamin B6, oxalic acid and vitamin C in chronic renal failure. Miner Electrolyte Metab 1999; 25: 352-356. Go to original source... Go to PubMed...
  5. Mydlík M, Derzsiová K. The 50-year history of the Nephrology Department in Košice (Slovak Republic). J Nephrol 2006; 19 (Suppl 10): S173-S177. Go to PubMed...
  6. Derzsiová K, Mydlík M. Pobrušnicový klírens a transfer bielkovín pri nepretržitej ambulantnej peritoneálnej dialýze. Vnitř Lék 1983; 29: 242-248. Go to PubMed...
  7. Mydlík M, Derzsiová K, Bohuš B. Zmeny vo funkčnom renálnom náleze po maratónskom behu, po 100-kilometrovom behu a po 24-hodinovom dlhotrvajúcom behu. Vnitř Lék 2009; 55 (Suppl 1): 103-107.
  8. Mydlík M, Derzsiová K, Mizla P et al. Diagnostika a liečba otravy etylénglykolom - rozbor 20 chorých. Vnitř Lék 2002; 48: 1054-1059. Go to PubMed...
  9. Derzsiová K, Mydlík M, Takáč M et al. Vitamín C v sére a leukocytoch pri chronickom zlyhaní obličiek. Čas Lék Čes 1983; 122: 1176-1179.
  10. Derzsiová K, Farkaš M, Mydlík M. Vitamín A a zinok v sére pri chronickom zlyhaní obličiek. Čas Lék Čes 1985; 124: 530-533.
  11. Derzsiová K, Mydlík M, Havriš Š et al. Vitamín B1 a horčík v erytrocytoch u chorých v dlhodobom dialyzačnom programe. Čas Lék Čes 1987; 126: 906-908.
  12. Mydlík M, Derzsiová K. Oxalic acid as a uremic toxin. J Renal Nutr 2008; 18: 33-39. Go to original source... Go to PubMed...
  13. Mydlík M, Derzsiová K. Vitamins and quality of life in hemodialysis patients. J Nephrol 2008; 21 (Suppl 13): S129-S133. Go to PubMed...
  14. Derzsiová K, Mydlík M. Metabolic changes of oxalate in chronic renal failure. In: F. Consolo, G. Bellinghieri, V. Savica (eds). 6th Taormina Course on Nephrology 2000, 149-161. Editoriale Bios, Cosenza - Italy, 2000.
  15. Derzsiová K, Mydlík M, Boldizsár J et al. Perorálne použitie železa s vitamínom C u hemodialyzovaných chorých. Vnitř Lék 2001; 47: 210-214. Go to PubMed...
  16. Mydlík M, Derzsiová K, Brátová M et al. Serum vitamin A, retinyl esters and vitamin E in nephrotic syndrome. Int Urol Nephrol 1991; 23: 399-405. Go to original source... Go to PubMed...
  17. Mydlík M, Derzsiová K. Erythrocyte vitamins B1, B2 and B6 and erythropoietin. Am J Nephrol 1993; 13: 464-466. Go to original source... Go to PubMed...
  18. Mydlík M, Derzsiová K. Metabolism of vitamin B6 and its requirement in chronic renal failure. Kidney Int 1997; 52 (Suppl 62): S56-S59.
  19. Mydlík M, Derzsiová K, Rácz O et al. Vitamin E-coated dialyzer and antioxidant defense parameters: three-month study. Semin Nephrol 2004; 24: 525-531. Go to original source... Go to PubMed...
  20. Mydlík M, Derzsiová K. Renal replacement therapy and secondary hyperoxalemia in chronic renal failure. Kidney Int 2001; 59 (Suppl 78): S304-S307. Go to original source... Go to PubMed...
  21. Mydlík M, Derzsiová K, Šváč J et al. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C and vitamin B6 during continuous ambulatory peritoneal dialysis. Artif Organs 1998; 22: 784-788. Go to original source... Go to PubMed...
  22. Mydlík M, Derzsiová K, Jenča A et al. Salivary oxalic and ascorbic acid in chronic renal failure. Proc. of selected papers of the XIII International Congress on Nutrition and Metabolism in Renal Disease. Merida (Mexico), February 28-March 4, 2006 (Edit. A. Treviño-Becerra, E. Pineda-Sanches, P. Trinida-Ramos). Medimond, Bologna (Italy), 39-44.
  23. Derzsiová K, Mydlík M, Petríková V et al. Hemoperfúzia teofylínu. Štúdia in vitro. Čas Lék Čes 1991; 130: 11-14.
  24. Derzsiová K, Mydlík M, Petríková V. Hemoperfusion study with carbamazepine in vitro. Int J Artif Organs 1999; 22: 730-733. Go to original source...
  25. Derzsiová K, Mydlík M, Petríková V et al. Haemoperfusion of Amitriptyline and Nortriptyline - an in Vitro Study. BANTAO J 2006; 4: 1-4.
  26. Derzsiová K, Mydlík M, Petríková V et al. Hemoperfúzia paracetamolu - štúdia in vitro. Akt Nefrol 2002; 8: 129-132.
  27. Mydlík M, Derzsiová K, Klán J et al. Hemoperfusion with alfa-amanitin an in vitro study. Int J artif Organs 1997; 20: 105-107. Go to original source... Go to PubMed...
  28. Derzsiová K, Mydlík M. XXVII. kongres Európskej spoločnosti pre umelé orgány (ESAO) "Most ku interdisciplinarite", 22.-25. septembra 2001, Gent (Belgicko). Vnitř Lék 2002; 48: 442-443.
  29. Mydlík M, Derzsiová K. 11. medzinárodný kongres pre výživu a metabolizmus pri chorobách obličiek, 29.-31. marca 2002, Nagoja (Japonsko). Vnitř Lék 2002; 48: 1088-1089.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.